Sanofi’s anti-CD38 antibody Sarclisa has struggled to make headway against Genmab and Johnson & Johnson’s rival Darzalex since it was first approved for multiple myeloma, but new data from the ...

Former Minister Kiri Allan talks to musician Anika Moa in a podcast RNZ didn't want you to hear. Video / RNZ Identity of Kiwi TV personality on cocaine charges kept secret; Why RNZ may have ...

In part 2 of our interview with Surbhi Sidana, MD, MBBS, American Society of Hematology and Stanford University, she delves into one of the hottest topics in the hematologic malignancy space today ...

Former Minister Kiri Allan talks to musician Anika Moa in a podcast RNZ didn't want you to hear. Video / RNZ Allan resigned as Justice Minister in July 2023 after crashing her ministerial car into ...

Sarclisa in combination with the VRd regiment was superior to VRd alone in improving survival in stem cell transplant ineligible multiple myeloma patients. No significant difference in serious adverse ...

Sanofi SNY announced that the FDA has approved the label expansion for the use of its multiple myeloma (MM) drug, Sarclisa (isatuximab). With this nod, Sarclisa is now approved in combination with ...

The FDA has approved Sanofi’s Sarclisa (isatuximab) in combination with a new chemotherapy regimen for advanced multiple myeloma, building on a first approval last year. This label extension ...